YOU ARE HERE:
Starting treatment news
page  of 15
 
Headline
Date
  Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection
02.10.08
  Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent
30.09.08
  More evidence that antiretrovirals reduce the risk of non-HIV illnesses at lower CD4 cell counts
23.09.08
  Patients staying on first-line HIV treatment combinations for longer
16.09.08
  Study shows patients in their 30s at time of HIV infection have best response to HIV therapy
10.09.08
  Poor results using non-medical HIV counsellors to screen for treatment eligibility in Malawi
03.09.08
  How does abacavir/3TC compare to tenofovir/FTC? ACTG5202 and GSK studies disagree
08.08.08
  Slowing CD4 cell decline with IL-2 allows HIV treatment to be deferred by 92 weeks
06.08.08
  Efavirenz superior to lopinavir/ritonavir in very advanced HIV, Mexican trial shows
06.08.08
  Swiss statement that ‘undetectable equals uninfectious’ creates more controversy in Mexico City
05.08.08
  Age may predict response to HIV treatment
31.07.08
  Many patients taking HIV drugs can now expect to live into their 70s
25.07.08
  Low level of drug-resistant strains common in untreated patients, but may not affect treatment
22.07.08
  Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
16.07.08
  Anti-HIV treatment as successful in South Africa as Switzerland - but starting treatment late is costing lives
09.07.08
  Kivexa restored to first-line status in final British guidelines - but with cautions
09.07.08
  'ART as prevention tool' policy announced for British Columbia
04.07.08
  Important changes to nevirapine dosing advice made by FDA
03.07.08
  Antiretroviral use increases survival sixfold in Thai patients with HIV and tuberculosis
27.06.08
  Atazanavir approved for first-line treatment in Europe
24.06.08

page  of 15